Breaking Through the Ice: Methylphenidate’s Role in a Senior’s 20-Year Quest For ADHD Diagnosis
DOI:
https://doi.org/10.53819/81018102t4277Abstract
Attention deficit and hyperactivity disorder (ADHD) remain a common neuropsychiatric complication in childhood rather than adulthood. However, recent cases of new diagnoses raise alarm over a potential increase in incidence in adulthood. This case series explores a 79-year-old woman with ADHD to capture insights into clinical practices, including diagnoses and treatments. This is a case report investigating a 79-year-old woman with a 20-year stint of self-medication to manage her ADHD. She presented at the clinic with a history of ADHD, but no symptoms at the time of incidence. Contrary to her knowledge, the Diagnostic and Statistical Manual, fifth edition, was used to determine her mental health and indicate a rational medication. The psychiatrists indicated Adderall XR and multivitamins to address her condition. The 79-year-old woman sought a legal prescription as she planned to relocate to France. She was diagnosed with ADHD, which is not a common incidence among adults and put on Adderall XR and multivitamins. Within four weeks, she reported remarkable improvement, including excellent task performance, concentration, and physical abilities. This case presents potential ADHD incidence in adulthood without awareness of symptoms among patients. A follow up confirmed improved task performance, concentration, alleviated hyperactivity, motor functions and attentiveness. These results set the differences in the effectiveness of unconventional and evidence-based interventions for ADHD among adults. It prompts policymakers to consider further investigations to establish a rational, evidence-based diagnosis and treatment. This case report marks the importance of evidence-based and rational drug use and disease management in adults. The old woman reported improved symptoms of ADHD following Adderall XR. Upon follow-up, psychiatrists indicated multivitamins to improve her well-being and improve her attentiveness. This combined therapy improved the woman’s motor functions, cognition concentration and task performance. This case represents common cases of unconventional treatments among patients and makes a clinical statement of adequate patient diagnosis and management of ADHD among adults.
Keywords: Methylphenidate, ADHD Diagnosis in Seniors, Long-term ADHD, Adult ADHD, Stimulant Medication
References
Abolfathi, M., Pasdar, Y., Kheiri, M., Fahim Irandoost, S., & Darabi, F. (2021). The effect of consuming multivitamin/ mineral supplements on elderly quality of life: Based on randomized control trial. https://doi.org/10.4103/jehp.jehp_129_20
American Psychiatric Association. (2024). What is ADHD.
Biederman, J., Disalvo, M., Green, A., Woodworth, K. Y., Law, C., Gabrieli, J. D. E., & Faraone, S. V. (2021). How Frequent Is Switching from an Initial Stimulant Family to the Alternative One in the Clinical Setting?: A Pilot Study of 49 Consecutively Referred Medication-Naive Adults with Attention-Deficit/Hyperactivity Disorder. Journal of Clinical Psychopharmacology, 41(3). https://doi.org/10.1097/JCP.0000000000001374
Faraone, S. V., & Biederman, J. (2002). Efficacy of adderall® for attention-deficit/hyperactivity disorder: A meta-analysis. Journal of Attention Disorders, 6(2). https://doi.org/10.1177/108705470200600203
Khan, M. U., & Aslani, P. (2021). Exploring factors influencing initiation, implementation and discontinuation of medications in adults with ADHD. Health Expectations, 24(S1). https://doi.org/10.1111/hex.13031
Michielsen, M., Semeijn, E., Comijs, H. C., Van De Ven, P., Beekman, A. T. F., Deeg, D. J. H., & Kooij, J. J. S. (2012). Prevalence of attention-deficit hyperactivity disorder in older adults in the Netherlands. British Journal of Psychiatry, 201(4). https://doi.org/10.1192/bjp.bp.111.101196
Pliszka, S. R. (2016). Attention-Deficit Hyperactivity Disorder Across the Lifespan. FOCUS, 14(1), 46–53. https://doi.org/10.1176/appi.focus.20150022
Post, R. E., & Kurlansik, S. L. (2012). Diagnosis and management of attention-deficit/Hyperactivity disorder in adults. American Family Physician, 85(9).
Price, M. E., Done, N., & Pizer, S. D. (2020). The Relationship Between Follow-up Appointments and Access to Primary Care. Journal of General Internal Medicine, 35(6). https://doi.org/10.1007/s11606-020-05785-3
Timothy E. Wilens, Joseph Bierdeman, & Thomas J Spencer. (2002). Attention deficit/hyperactivity disorder across the lifespan . Annual Reviews, 53, 113–131.
U.S. FOOD & DRUG ADMINISTRATION. (2018). FDA takes important steps to encourage appropriate and rational prescribing of opioids through final approval of new safety measures governing the use of immediate-release opioid analgesic medications.
